Introduction The global pandemic of coronavirus disease 2019 (COVID‐19) is caused by the
severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). It seems that there is an …

Chronic myeloid leukemia is a malignancy of bone marrow that affects white blood cells.
There is strong evidence that disease progression, treatment responses, and overall clinical …

Abstract HSPA5 (BiP, GRP78) has been reported as a potential host-cell receptor for SARS-
Cov-2, but its expression profiles on different tissues including tumors, its susceptibility to …

Limited information is available on the impact of the COVID‐19 pandemic on the
management of chronic myeloid leukaemia (CML). The Campus CML network collected …

Purpose of Review COVID-19 is highly contagious; since it was first identified, the virus has
rapidly spread to more than 100 countries and was declared a pandemic on March 11 …

Previous studies reported that COVID-19 patients with cancer had higher rates of severe
events such as intensive care unit (ICU) admission, mechanical ventilation (MV) assistance …

Despite the great technological and medical advances in fighting viral diseases, new
therapies for most of them are still lacking, and existing antivirals suffer from major limitations …

Main aim of this systematic review is to quantify the risk and identify predictors of clinical
evolution of SARS‐CoV‐2 in hematological patients compared to different control …

Background Patients with hematological malignancies are at an increased risk of SARS‐
CoV‐2 disease (COVID‐19) and adverse outcome. However, a low mortality rate has been …

To explore the prevalence and severity of COVID-19 and the mental health during the
Omicron pandemic in patients with chronic myeloid leukemia (CML), a cross-sectional …